Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
Scott Weiner appointed to Strategic Advisory Board of Florida Institute for the Commercialization of Public Research
News | 05. 14. 2009
The Florida Institute for the Commercialization of Public Research (The Institute) today announced the formation of its Strategic Advisory Board; 15 distinguished industry experts who will provide counsel on technical challenges associated with raising early stage capital and technology commercialization.
